 Your new post is loading...
Your new post is loading...
Scoop.it!
PubMed comprises more than 21 million citations for biomedical literature from MEDLINE, life science journals, and online books. Citations may include links to full-text content from PubMed Central and publisher web sites. 
No comment yet.
Sign up to comment
Scoop.it!
One of the most promising new approaches in modern cancer treatment is immunotherapy or biotherapy, the development of methods to augment and enhance the body's natural tendency to defend itself against malignant ...
Scoop.it!
The usefulness of interferon-gamma (IFN-γ) release assays for tuberculosis screening before tumor necrosis factor-alpha (TNF-α) antagonists and for monitoring during treatment is a contraversial issue.
Scoop.it!
Actinium Pharma gets rights to develop & commercialize BC8 monoclonal antibody from FHCRC (Actinium Pharma gets rights to develop & commercialize BC8 monoclonal antibody from FHCRC http://t.co/7ZIExyFe...)...
Scoop.it!
Immunovaccine's DPX-Survivac Featured in Presentation at Federation of ...MarketWatch (press release)Immunovaccine's DPX-Survivac Featured in Presentation at Federation of Clinical Immunology Societies Conference (FOCIS 2012).
Scoop.it!
Gastroenterology Medical Article: Long-term outcome of a third anti-TNF monoclonal antibody after the failure of two prior anti-TNFs in inflammatory bowel disease (Long-term outcome of a third anti-TNF monoclonal antibody after the failure of two ...
Scoop.it!
Federal authorities have given the go-ahead to human trials that will use a new stem cell treatment to repair heart attack damage.
|
Scoop.it!
Tokyo-based Chugai Pharmaceutical Co., Ltd. has officially opened a new laboratory in Singapore that will conduct research on new antibody drugs.
Scoop.it!
In addition to activation of NK-surface stimulatory receptors, therapeutic monoclonal antibodies such as the anti-KIR monoclonal antibody blocking inhibitory signaling in NK cells have been tested in clinical trials on acute myeloid leukemia and...
Scoop.it!
These include non-specific stimulators, cytokines, monoclonal antibodies, radiolabelled antibodies, immunotoxins, and cell-based therapy (reviewed in [3]). Further ..... Committee for Tumor Immunology and Bio-therapy (TIBT) ...
Scoop.it!
RT @AllergyNet: Readable immunology, with memorable metaphors MT @JuanCIvancevich Chronic T-cell exhaustion. Full text.
Scoop.it!
Immunology: Vaccine Hope for Virile VirusScience Daily (press release)Exploiting the early immune response in Chikungunya fever promises to provide protection.
Scoop.it!
NIHNews: NIH Awards Funding for New Centers for HIV/AIDS Vaccine Immunology & Immunogen Discovery (CHAVI-ID) http://t.co/OgbkHCMs...
|
